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Abstract
Objective—The aims of this study were twofold: 1) to provide a brief introduction to the
prospective, longitudinal Great Smoky Mountains Study and review recent findings; and 2) to use
this sample to conduct an epidemiologic analysis of common childhood anxiety disorders.
Method—The population-based Great Smoky Mountains Study assessed 1,420 participants from
11 counties in southeastern US up to 11 times between ages 9 and 26 with the structured Child and
Adolescent Psychiatric Assessment and its upward extension, the Young Adult Psychiatric
Assessment.
Results—The U-shaped age prevalence curve for any anxiety disorder was the product of high
levels of childhood separation anxiety and adult panic, agoraphobia, and generalized anxiety. Over
1 in 5 subjects met criteria for an anxiety disorder by early adulthood. In terms of cumulative
comorbidity, there was evidence of overlap between anxiety disorders, but the level of overlap
was generally consistent with what is seen amongst other common childhood disorders. All
childhood anxiety disorders were associated with adverse functioning in at least one young adult
functional domain with the poorest outcomes for childhood generalized anxiety and DSM-III-R
overanxious disorder.
Conclusion—Clinically significant anxiety is a common mental health problem to have had by
adulthood. There was little evidence to support the consolidation of anxiety disorders, and some
evidence to justify reintroduction of DSM-III-R overanxious disorder. The transition to young
adulthood appears to be a key period for understanding the development of common adult anxiety
disorders such as panic and agoraphobia.
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Over 50 years ago, Lapouse and Monk asserted that “One of the great psychiatric dilemmas
of our time is the decision as to what is normal and what is abnormal in human behavior” (p.
1134).1 The controversy surrounding the recent publication of DSM 5.0 only confirms that
this question continues to bedevil child psychiatry and motivate its investigators. Lapouse
and Monk chose to address this dilemma by beginning one of the first epidemiological
studies in child psychiatry on 482 children ages 6 to 12 in Buffalo, NY. There is now a long
history of such studies in child psychiatry and they have gone far beyond the “mere counting
of heads” (p. 646)2 to inform our etiological models of psychiatric disorders, to describe
continuities and discontinuities across development, and to link mental health with other
areas of functioning.
This paper will review one such study that was begun in the early 1990s to study the
development of childhood psychopathology in 11 rural counties in western North Carolina3.
To date, the Great Smoky Mountains Study has been following the original subjects for
close to 20 years. The first part of this paper will provide a brief review of this study and
draw attention to a number of recent findings—that can only be derived from a prospective,
longitudinal study of this kind. The second part of the paper uses this distinctive study to
conduct a developmental epidemiologic analysis of individual anxiety disorders from
childhood to adulthood.
The Great Smoky Mountains Study
The Great Smoky Mountains Study (GSMS) was originally designed to examine the
prevalence of common childhood psychiatric disorders, their development over time and use
of mental health services in a predominantly rural area of the southeastern United States. At
the time this study began there was no national survey to estimate the public health burden
of childhood mental health problems or to identify the extent of met and unmet need.
Furthermore, none of the ongoing epidemiologic studies had focused on rural areas where
children are often isolated from access to specialty mental health services.
Given these aims, the study design had to balance identifying psychiatric cases with
producing population prevalence estimates. A random household design might produce
accurate prevalence estimates, but lack sufficient cases to develop risk models for individual
psychiatric disorders. In contrast, a clinical sample would maximize case identification, but
be of little use for epidemiologic prevalence and comorbidity estimates4. A screening-
stratified sampling design achieves both aims by oversampling children scoring high on a
screener, and then using sampling weights related to probability of selection to produce
unbiased prevalence estimates5. Figure 1 shows how this design was implemented in the
GSMS.
The GSMS area contains the Qualla Boundary, a federal reservation that is home to the
Eastern Band of the Cherokee Indians, which has 8,000 enrolled members. While they make
up only about 3% of the population of the study area, they were oversampled using the same
screening procedure but recruiting everyone irrespective of their screen score. This provided
a sufficient sample of American Indian children for computing epidemiologic estimates and
testing risk pathways within this understudied group.
The original sample of 1,420 children included three cohorts ages 9, 11, and 13 at baseline.
Originally, assessment interviews were completed with the child and one parent (primarily
mothers) each year as close to the child’s birthday as possible (see Table 1). This strategy of
annual assessments was continued through age 16 with a few exceptions due to financial
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restraints. Since age 16, the aim has been to interview all subjects at specific ages, a practice
that is ongoing.
Originally, the primary assessment target was psychiatric function and service use, but the
study also assessed related economic, psychosocial, and physical health constructs including
family and community resources, family functioning, and exposure to adverse events, and
physical health and development. Two finger-prick blood samples were collected with
standardized collection paper at each in-person visit yielding 10 spots total. These dried
bloodspots have since been assayed for sex steroid levels, hypothalamic–pituitary–adrenal
(HPA) and immune function, and DNA methylation status. More recently, the focus of
assessment has shifted to measuring long-term outcomes of psychiatric problems including
physical health function, criminality, labor force outcomes, and adult social functioning. The
competing aims of a prospective, longitudinal study are to collect similar measurements on
similar constructs over time that allow one to assess developmental variation unaffected by
measurement variance while simultaneously amending assessments to be up-to-date with
scientific standards and relevant to the subject’s current developmental stage.
Like many such long-term studies, the aims of GSMS have evolved. The sustaining value of
such epidemiologic studies is derived from the methodological triangle of representative
sampling, a prospective, longitudinal design, and cross-domain assessment. This value is
maintained by minimizing attrition, continuous updating of the assessment battery, and
selective adoption of novel methods. Below we provide three examples of recent GSMS
findings that can only be derived from this type of prospective-longitudinal study, but were
opportunities unforeseen at the study’s inception.
Depression and Puberty
One of the most well-established findings in developmental psychopathology is the female
predominance in unipolar depressions that appears around the age of 136, 7. This pattern
implicates puberty, but puberty is a biologically driven developmental transition with
complex secondary effects on social, emotional, and sexual development8. The longitudinal
GSMS design allowed us to disentangle age from pubertal timing and pubertal stage. It was
the transition to Tanner stage III of puberty that was associated with a sharp increase in rates
of DSM-IV unipolar depressions in girls, not the relative timing of this transition9. We next
tested whether specific morphological changes or the hormonal changes underlying them
accounted for the increased susceptibility to depression by assaying dried blood spots
collected at each assessment for gonadal hormones and gonadotrophins (luteinizing
hormone, follicular stimulating hormone, estradiol, testosterone). The Tanner stage effect
was entirely explained by increasing levels of estradiol and testosterone10. Repeated
measures of the same subjects, including sex steroids, proved necessary for testing
competing pathways associated with the pubertal increase in female depression.
Natural Experiment
Children from impoverished families have higher levels of emotional and behavioral
problems11, 12. The challenge has been separating the effect of intergenerational social drift
from social causation. The optimal study design would involve random assignment of
families to different income strata13 but such experiments are rare. Four years into data
collection for GSMS, a natural experiment was presented in which income levels in an entire
community were raised—regardless of prior income status—as a gambling casino was
opened on the American Indian reservation. Every man, woman, and child within the tribe
received a portion of the profits every 6 months (children’s earnings were paid into a trust
fund until adulthood). This income supplement (which reached an annual level of $6,000 by
2001) raised many previously impoverished families above the federal poverty line. Moving
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out of poverty reduced children’s rates of behavioral psychiatric symptoms to levels similar
to those who were never poor14. These children continued to display lower rates of
psychopathology, particularly substance disorders, into young adulthood15. This natural
experiment provided support for the social causation theory that family poverty itself can be
sufficient to increase risk for childhood behavior problems.
Cumulative Prevalence
Within any 3-month period during childhood, 13.3% of GSMS subjects met criteria for a
DSM-IV disorder16. It is reasonable to suppose that the group of children meeting diagnostic
criteria changes over time. This raises the question of how many children are affected by
psychiatric disease at some point before adulthood. Lifetime prevalence estimates from a
single retrospective interview suggest that about half of adults will meet criteria for a DSM-
IV disorder by age 7517, but such a design is susceptible to bias. The repeated assessments
from GSMS allowed us to estimate the cumulative prevalence of psychiatric problems with
minimal risk of recall bias or forgetting. Despite the modest 3-month prevalence estimates,
we found that 61.1% of the sample had met criteria for a DSM disorder by age 21. An
additional 21.4% of participants displayed subclinical psychiatric problems but never met
full criteria for a DSM disorder. This brought the cumulative psychiatric burden to 82.5%,
despite only following subjects to age 21 and only assessing 3-month periods at each
interview. Though commonly perceived as being uncommon or even rare, this study
suggests most young adults have experienced mental illness at some period in development.
The three example findings described above underscore the value of epidemiologic studies
followed prospectively across development and the importance of exploiting these
uncommon resources. Accordingly, in the remainder of this paper, we leverage the 20-year
longitudinal design of the GSMS to conduct an epidemiologic analysis of common anxiety
disorders. Results from these analyses will inform our understanding of the developmental
course and outcomes of individual anxiety disorders and their overlap.
Anxiety Disorders
A recent meta-analysis found that 12.3% of children have met criteria for an DSM-IV
anxiety disorder at some point in middle childhood and 11.0% in adolescence18. It is
estimated that between 15% and 30% of children and adolescents have been diagnosed with
an anxiety disorder at some point in childhood19, 20, with conflicting evidence about whether
females are more susceptible than males (evidence for21, 22; evidence against23, 24). Overall,
anxiety disorders are common, and in females, they may be more common than any other
disorder category16, 24.
This conclusion, however, involves grouping together a host of disorders with distinct
criteria and developmental features. Is this grouping justified? In his discussion of child
psychiatric diagnosis and classification, Rutter suggested that in the case of anxiety
disorders “there is something to be said in favor of eliminating all subcategories” (p. 649).25
He argued for such consolidation based on their high levels of co-occurrence and
quantitative genetics findings. Grouping anxiety disorder has also been useful in
determining the stability of anxiety and the association between childhood anxiety and long-
term outcomes26, and in identifying underlying neural circuitry27. Furthermore, cognitive
behavioral therapy and selective serotonin reuptake inhibitors are effective for a range of
different anxiety disorders (e.g.,28). Such consolidation would provide a simplified
taxonomy that is both consistent with best practice treatment recommendations and a limited
research base on differences between individual anxiety disorders.
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On a range of other metrics, however, there is evidence that individual anxiety disorders
differ in important ways. Pine pointed out the unique course of many anxiety disorders in
terms of developmental course, familial aggregation, comorbidity patterns, risk factors and
biology while ceding the ‘logic’ of grouping such disorders for clinical purposes29.
Furthermore, different childhood anxiety disorders predict different adult disorders
(see19, 30). For example, the apparent association of childhood anxiety disorders with adult
depression16, 21, 31 is accounted for by generalized anxiety only30. Similarly, different
anxiety disorders may have differentiated predictions of other domains of later functioning.
If individual anxiety disorders tell us something specific about one’s long-term prognosis,
then such distinctions may useful for clinicians and researchers alike.
This paper uses the GSMS to present a developmental epidemiologic analysis of childhood
anxiety disorders. We will present the following: 1) developmental patterns of individual
anxiety disorders; 2) cumulative prevalence estimates for individual disorders; 3) cumulative
comorbidity rates between individual anxiety disorders; and 4) adult functional outcomes of
individual childhood anxiety disorders. Together, these analyses provide a broad picture of
the course and outcomes of individual disorders and their overlap that is lacking in the
current literature.
Our previous work has implicated DSM-III-R overanxious disorder as a predictor of adult
panic disorder over and above the contribution of other anxiety disorders30. Like GSMS, the
New York Child Longitudinal Study found that overanxious disorder predicted adult
psychiatric status and the authors suggested that this disorder should be retained in our
diagnostic system21. These findings suggest that the DSM-IV generalized anxiety may not be
sufficient to assess the full range of “generalized anxiety” in children and adolescents. We
believe that overanxious disorder continues to merit attention in our ongoing efforts to
clarify the heterogeneity of childhood anxiety and thus we include it in all analyses below.
Method
The sampling, methods and sample characteristics were described above. Additional detail is
available in prior publications3, 16. Of the 1,420 subjects, 51.1% were female (unweighted
n=630), 6.9% African American (n=88) and 3.7% American Indian (n=349). 34.3% (n=661)
of subjects came from families that fell below the federal poverty line at least once during
childhood.
Procedure
All interviewers were residents of the study area, had at least bachelor's level degrees, and
received 1 month of training and ongoing quality control. Before the interviews began,
parents and adult participants signed informed consent forms; informed assent forms were
signed by minor children. Approval for this protocol was obtained from the Duke University
Medical Center Institutional Review Board.
Measures
DSM-IV psychiatric disorders were assessed using 1) the Child and Adolescent Psychiatric
Assessment (CAPA)24 until age 16, and 2) the upward extension of the CAPA, the Young
Adult Psychiatric Assessment (YAPA)25 at ages 19, 21, and 24–26. Both a parent and the
participating child were interviewed at ages 9–16; beginning at age 19 only the participant
was interviewed. All interviews were coded by a trained interviewer and then checked by a
supervisor. Anxiety disorders assessed included separation anxiety, generalized anxiety,
social phobia, specific phobia, agoraphobia, and panic disorder, as well as DSM-III-R
overanxious disorder. The time frame for determining the presence of psychiatric symptoms
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was the previous three months. Onset dates for all symptoms were also assessed, and were
used in diagnostic algorithms when DSM-IV criteria required a symptom duration of 3+
months. A detailed glossary provides the operational rules for identifying clinically
significant symptoms. Scoring programs for the CAPA and YAPA, written in SAS by the
senior authors, combined information about the date of onset, duration, and intensity of each
symptom to create diagnoses according to the DSM. A symptom was counted as present if
reported by either parent or child or both, as is standard in child and adolescent
epidemiological studies, approximating the process of combining information from multiple
informants in clinical practice. Two-week test-retest reliability of CAPA diagnoses in
children aged 10 through 18 is comparable to that of other structured child psychiatric
interviews23, 32. Construct validity as judged by 10 different criteria including comparison to
other interviews and ability to predict mental health service use is good to excellent33. All
measures, a glossary, and codebooks are provided at http://devepi.duhs.duke.edu/
instruments.html.
Assessment of Adult Functioning
Adult outcomes were assessed at ages 19, 21, and 24–26. All outcomes were assessed
through self-report interviews with the Young Adult Psychiatric Assessment (YAPA)34, 35.
The objective was to provide a broad profile of adult functioning across three domains:
health, financial/educational, and social. Individual dichotomous indicators in each domain
were aggregated into scales. These scales were standardized (mean: 0; SD: 1). Thus, “0”
indicates the mean adult functioning in this sample). Additional information about
individual indicators is available upon request from the first author.
Health Functioning—Participants reported being diagnosed with a serious/chronic illness
or being in a serious accident at any point during young adulthood. Having a sexually
transmitted disease was coded if the participant reported testing positive for herpes, genital
warts, chlamydia, or HIV. Obesity was defined as BMI greater than 30 kg/m2. Regular
smoking was defined as smoking > 1 cigarette per day for an extended period of time. A
physical health problems survey adapted from CDC National Health Interview Survey
(NIHS) Child Supplement (1988) was administered at all interviews. This assessed self-
reported poor health, illness contagion, and slow illness recovery.
Financial/Educational Functioning—Being impoverished was coded based upon
Census Bureau thresholds based on income and family size36. High school dropout and
completion of any college completed were coded based upon the subject’s educational status
at the last adult assessment. The following job problems were assessed at each assessment:
being dismissed or fired from a job and quitting a job without financial preparations. Finally,
other financial problems were assessed using self-report: failing to honor debts or financial
obligations and being a poor manager of one’s finances (difficulty paying bills on time, no
resources for emergencies, had car repossessed, or debt turned over to collector).
Social Functioning—Marital, parenthood, and divorce status were determined through
self-reports at ages 24–26. The quality of the participant’s relationship with their parents,
spouse/significant other, and friends was assessed at each assessment including arguments
and violence. Variables were included to indicate any self-reported violence in a primary
relationship, a poor relationship with one’s parents (based on either having no contact with
parent or contact that is mostly conflictual and negative), no reported best friend or
confidante, and difficulty making or keeping friends.
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Ninety-seven point five percent of participants provided more than one assessment, with
over 79.4% of participants contributing at least 6 assessments (median = 7; mode=9; range
for completed assessments: 1 to 11). Thirty participants had died by age 26. Initial
psychiatric state was unrelated to later missingness (OR=1.0, 95%CI 0.9, 1.1, p= .34), but
individuals with more observations have more opportunities to meet criteria for a disorder.
Therefore, cumulative prevalence and comorbidity analyses were completed on imputed
datasets with SAS PROC MIANALYZE was used to read parameter estimates and
associated covariance matrices for each imputed dataset and to derive valid statistical
inferences and estimates37. Imputation details are available from the first author by request.
Analytic Strategy
As discussed above, sampling weights were applied to adjust for differential probability of
selection and to insure that results represent unbiased estimates for the original population
from which the sample was drawn. All reported prevalence rates are weighted. In addition,
sandwich type variance corrections38 were applied to adjust for the parameter and variance
effects induced by the sampling stratification. Weighted regression analyses were completed
using PROC GENMOD in SAS 9.239.
Results
Prevalence by Age
Figure 2a shows the sex-specific 3-month prevalence rates from age 9 to 26 for having at
least one anxiety disorder (i.e., social phobia, specific phobia, separation anxiety disorder,
generalized anxiety disorder, panic disorder, and agoraphobia). The overall pattern is U-
shaped with a sharp decrease in middle childhood followed by increasing levels from early
adolescence to young adulthood. While the rates for females were slightly higher at various
timepoints, this difference did not meet statistical significance overall, although there was
evidence of a female preponderance in midadolescence and young adulthood (p=0.032 for
age 15+).
Notably, the overall anxiety prevalence curve was not matched by any of the individual
anxiety disorder prevalence curves. Thus, the overall anxiety disorder curve proved to be the
average of several—quite different—age distributions of individual anxiety disorders that
was not representative of any single disorder. Separation anxiety (Figure 2b) was common
in middle childhood, but became vanishingly rare by early- to midadolescence. Social and
specific phobia (Figures 2c and 2d, respectively) were both relatively uncommon (1% or
below) across development. In contrast, generalized anxiety disorder increased across
adolescence with rates generally higher for females after mid-adolescence (Figure 2e;
p=0.035 for age 15+). Both agoraphobia and panic disorder (Figures 2f and 2g, respectively)
were rare in childhood and adolescence then increased in young adulthood. For panic
disorder, there was evidence that rates were higher in females in young adulthood, although
even here the difference was not statistically significant (p=0.110 for age 19+). DSM-III-R
overanxious disorder (Figure 2h) was more common in females across development, but did
not vary by age.
Concurrent Comorbidity Among Anxiety Disorders
It is well established that anxiety disorders, like all common childhood disorders, frequently
co-occur. 3.6% (SE=0.4) of participants met criteria for an anxiety disorder at any given
time, but only 0.5% of subjects or 13.8% of the those with an anxiety disorder met criteria
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for 2 or more anxiety disorders at any point in time. Thus, the majority of anxiety disorder
cases were noncomorbid.
Cumulative Prevalence
Cumulative prevalence looks at the likelihood of having met criteria for a disorder at any
observation by age 26. Table 2 shows the cumulative 3-month rates of anxiety disorder by
age 26. Over 1 in five subjects (22.7%) had met criteria for an anxiety disorder by early
adulthood. This estimate increased to 1 in 4 children when DSM-III-R overanxious disorder
was included. The cumulative prevalence rate of any anxiety disorder was higher in females;
this sex difference, however, was only statistically significant when overanxious disorder
was included. The most common DSM-IV anxiety disorder was generalized anxiety
followed by agoraphobia, separation anxiety, and panic disorder. DSM-III-R overanxious
disorder was the most common disorder overall and the only disorder that was significantly
more common in females than males.
Cumulative Comorbidity
Cumulative comorbidity shows how anxiety disorders overlap with one another over time as
well as with other disorders. Table 3 displays the cumulative comorbidity rates from age 9 to
age 26. Of the 20 possible associations among anxiety disorders, 11 met standards for
statistical significance and all odds ratios were greater than 1. Generalized anxiety was most
likely to be comorbid, overlapping with all other anxiety disorders except for agoraphobia.
All other anxiety disorders overlapped with at least 2 other anxiety disorders with most odds
ratios of association falling between 3 and 5. Higher levels of comorbidity were seen in
social phobia with specific phobia where more than half of individuals with a specific
phobia had met criteria for social phobia. DSM-III-R overanxious disorder also displayed
high levels of overlap with generalized anxiety and panic disorder although in neither cases
did more than half of the cases overlap.
Table 3 also displays the overlap between anxiety disorders and depression and behavioral
disorders (conduct disorder, oppositional defiant disorder, attentiondeficit/ hyperactivity
disorder [ADHD], and substance disorders). Generalized anxiety and panic disorder were
associated with both categories; separation anxiety and social phobia were associated with
depression only; agoraphobia and specific phobia (not shown) were not associated with
either.
Long-Term Outcomes
Figure 3 displays the associations between childhood anxiety status (up to age 16) and three
types of outcomes in young adulthood (ages 19, 21, and 24–26): health outcomes, financial
outcomes, and interpersonal functioning. As compared to those with no childhood anxiety
disorder, each individual childhood anxiety disorder was associated with adverse
functioning in at least one young adult functional domain. Both generalized anxiety and
overanxious disorder had poor functioning in all domains. Separation anxiety was associated
with poor health outcomes and social phobia was associated with interpersonal problems.
Discussion
Since the advent of DSM-III in 1980, no new anxiety disorders have been added and 2
childhood disorders have been consolidated with adult counterparts (avoidant disorder with
social phobia and overanxious disorder with generalized anxiety)40. One question for future
iterations of the DSM is whether further consolidation is warranted. Put differently, if the
core feature of a set of disorders is shared, then what should be the standard for keeping
these disorders separate? In the absence of an accepted standard, the current study uses a
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prospective, longitudinal study to look at similarities and differences across individual
anxiety disorders.
The overall age prevalence curve of any anxiety disorder was not matched by the curve of
even a single individual anxiety disorder. The age peaks in the overall rate of anxiety
disorders were driven by different individual disorders with separation anxiety common
early in development and generalized anxiety, panic, and agoraphobia common in young
adulthood. The most prominent increases in anxiety disorders were associated with the
transition to early adulthood, and the emerging anxiety landscape of young adulthood
involves disorders without a specific, circumscribed fear (like specific phobia) and little
evidence of attenuation with time. Unlike the pubertal transitions--which are distinctly
biologically driven--the move from adolescence to young adulthood is characterized by
distinct psychosocial events marking the transitions to adulthood, including independent
living and fulltime employment. By their mid- 20s, a quarter of subjects had met criteria for
an anxiety disorder. This is not far from the projected lifetime prevalence of 31.5% given by
the National Comorbidity Survey Replication17. The cumulative rates of generalized
anxiety, panic and agoraphobia already met or exceeded the projected lifetime rates from
studies based on retrospective recall by adults, casting further doubt upon accuracy of
lifetime retrospective recall41, 42. This is not to suggest that prospective, longitudinal studies
are a panacea. Cumulative rates from such studies are always going to vary by the frequency
of assessments, the period assessed, and the selection of informants. What is the true lifetime
prevalence of anxiety disorders then? No single study can provide a satisfactory answer, but
our findings suggest that anxiety is a common mental health issue to have had by adulthood
and much more common than has previously been suggested.
At any given point in time it was uncommon for an individual with an anxiety disorder to
have a comorbid anxiety disorder. This is not unexpected given the distinct age-prevalence
pattern of individual disorders. Was the overlap between anxiety disorders over time higher
than observed between other pairs of common disorders? There was evidence of overlap
between anxiety disorders, as is the norm in child psychopathology43, but the levels of
overlap were only slightly higher than is common between childhood disorders (ORs
between 3 and 6 in Table 3). By way of comparison, the odds ratio of association between
depressive disorders and behavioral disorders was 3.4 (95% CI: 2.0–5.7). There was one
exception: social phobia and specific phobia had a degree of overlap that might support the
consolidation of these disorders. The other potential target for consolidation was of an
anxiety with a nonanxiety disorder: generalized anxiety with depression. This is consistent
with a host of prior studies44–46.
One of the ongoing questions regarding anxiety disorders is about their long-term prognosis.
Separation anxiety disorder, for example, has a time-limited prevalence pattern—by
adolescence it is nearly nonexistent. This contributes to the idea that some anxiety disorders
may involve temporary distressing fears and worries but leave little lasting long-term effect.
We have previously chronicled the links between childhood anxiety status and specific
psychiatric outcomes into adulthood19, 30. Here, we found that these long-term effects
extend beyond psychiatric functioning: each childhood anxiety disorder was associated with
poor functioning in an important adult functional domain.
Generalized anxiety was intended to replace DSM-III-R overanxious disorder in identifying
children with nonspecific, uncontrollable worry. Although these disorders were highly
comorbid, most cases of either disorder were not comorbid with the other. The
reintroduction of overanxious disorder to the DSM nosology has been proposed on the
grounds that the overanxious criteria do not overlap with depression as is the case with
generalized anxiety44. Our findings suggest that the overanxious criteria identified an
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independent group of children at risk for adult psychopathology and as well as other
problems. As is, there is every reason for clinicians to continue (or to begin again) to assess
the criterial symptoms of this disorder in their attempts to address current distress and to
identify those patients at risk for long-term emotional problems.
The strengths of the sampling procedure, study design and assessment protocol have been
discussed in detail, but the current sample is only representative of children from the area
sampled, not all children in the US. Second, while the study is able to look at anxiety across
middle childhood, adolescence, and early adulthood, it is clear that many children have
already met criteria for an anxiety disorder by middle childhood47. Finally, the assessments
sought to maximize accuracy of recall by focusing on a limited 3-month period, but this
leaves 9 months unassessed between annual interviews. As such, our estimates are likely to
represent the lower limit of the burden of anxiety disorders.
These findings provide little support for arguments to consolidate anxiety disorders, but they
also have implications for our research agenda for anxiety disorders. Given the evidence of
modest overlap between anxiety disorders, is there evidence of genetic, epigenetic,
hormonal, or neural specificity for the individual disorders? Next, the period with the most
dramatic changes in the rates of anxiety was the transition from adolescence to early
adulthood. What aspects of this transition are associated with increased risk for agoraphobia,
panic and generalized anxiety? Is this increased susceptibility simply a function of increased
stress associated with the young adult transitions? Finally, all childhood anxiety disorders
were associated with poor health functioning in young adulthood. Depression has been
studied in relation to a range of physical health problems including heart disease and
diabetes48, 49. This finding suggests that similar attention should be paid to the physiological
costs of anxiety.
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Ascertainment figure for Great Smoky Mountains Study.
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Age-prevalence estimates for DSM anxiety disorders: A) Any DSM-IV anxiety disorder; B)
Separation anxiety; C) Social phobia; D) Specific phobia; E) Generalized anxiety; F) Panic
disorder; G) Agoraphobia; H) DSM-III-R overanxious disorder.
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Associations between childhood anxiety disorder status and outcomes in young adulthood.
Note: Starred bars are significantly different from the group with no childhood anxiety
disorder. For health outcomes, subjects with a history of either separation anxiety (SEP) or
generalized anxiety (GAD) had poor outcomes (SEP: β=0.63, SE=0.26, p=0.015; GAD:
β=0.66, SE=0.17, p<0.001), but not those with a history social phobia (SOC: β=0.26,
SE=0.36, p=0.47. Subjects with generalized anxiety had more financial problems in young
adulthood (GAD: β=0.51, SE=0.19, p=0.006). This was not the case for those with
separation anxiety or social phobia (SEP: β=0.33, SE=0.23, p=0.15; SOC: β=−0.04,
SE=0.35, p=0.91). Individuals with a history of either social phobia (SOC: β=1.09, SE=0.53,
p=0.042) or generalized anxiety (GAD: β=−0.47, SE=0.22, p=0.034) had poor social
outcomes. Those with a history of separation anxiety (SEP: β=−0.28, SE=0.18, p=0.13 did
not have significantly worse interpersonal outcomes than those with no history of childhood
anxiety. Individuals with childhood overanxious disorder had poor health (β=1.24, SE=0.23,
p<0.0001), financial (β=0.58, SE=0.24, p=0.017) and social outcomes (β=1.10, SE=0.27,
p<0.0001).
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